Multiple Sclerosis Resource Centre

Welcome to the Multiple Sclerosis Resource Centre. This website is intended for international healthcare professionals with an interest in Multiple Sclerosis. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review

Gurpreet K Reen, Eli Silber, Dawn W Langdon

Journal of the Neurological Sciences, Volume 375, 15 April 2017, Pages 107–122


Classifying PML risk with disease modifying therapies

Joseph R. Berger

Multiple Sclerosis and Related Disorders, Volume 12, February 2017, Pages 59–63

Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: A systematic review

Rui Li, Xiaobo Sun, Yaqing Shu, Zhifeng Mao, Li Xiao, Wei Qiu, Zhengqi Lu, Xueqiang Hu

Multiple Sclerosis and Related Disorders, Volume 12, February 2017, Pages 23–28

Multiple sclerosis: Therapeutic applications of advancing drug delivery systems

Sanam Dolati, Zohreh Babaloo, Farhad Jadidi-Niaragh, Hormoz Ayromlou, Sanam Sadreddini, Mehdi Yousefi

Biomedicine & Pharmacotherapy, Volume 86, February 2017, Pages 343-353

Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review

Gurpreet K Reen, Eli Silber, Dawn W Langdon

Journal of the Neurological Sciences, Volume 375, 15 April 2017, Pages 107–122